# NeoVista

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neovista

- Industry: Medical Devices & Equipment
- Headquarters: Newark, US
- Website: www.neovistainc.com
- Total disclosed funding: $106M
- Latest round: Series F (May 11, 2012)
- Investors on record: 6

## About

NeoVista , Inc., is based in Newark, US and operates as a developer of medical technologies for the treatment of wet age-related macular degeneration.

## Funding rounds

- Series F, May 11, 2012, $6M — Carlyle Group, Essex Woodlands, Versant Ventures, Accuitive Medical Ventures, MPM BioImpact
- Series E, Jan 28, 2011, $34M — Carlyle Group, Essex Woodlands, Versant Ventures, Accuitive Medical Ventures, SV Health Investors, MPM BioImpact
- Series D, Mar 16, 2009, $18M — Carlyle Group, Essex Woodlands, Versant Ventures, Accuitive Medical Ventures, SV Health Investors, MPM BioImpact
- Series C, Dec 6, 2006, $41M — Carlyle Group, Essex Woodlands, Versant Ventures, Accuitive Medical Ventures, SV Health Investors, MPM BioImpact
- Series B, Mar 15, 2006, $5.3M — Carlyle Group, Versant Ventures, Accuitive Medical Ventures, SV Health Investors
- Series A, May 25, 2004, $2M — Carlyle Group, Versant Ventures, SV Health Investors
- Seed, Jun 1, 2003 — SV Health Investors

## Investors

- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Seed, Series A, Series B, Series C, Series D, Series E
- Carlyle Group (https://capitalatlas.ai/funds/carlyle-group) — Series A, Series B, Series C, Series D, Series E, Series F
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A, Series B, Series C, Series D, Series E, Series F
- Accuitive Medical Ventures (https://capitalatlas.ai/funds/accuitive-medical-ventures) — Series B, Series C, Series D, Series E, Series F
- Essex Woodlands (https://capitalatlas.ai/funds/essex-woodlands) — Series C, Series D, Series E, Series F
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series C, Series D, Series E, Series F